Medpace Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
During the three months ended December 31, 2025, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
- 77 -
| Action | Date | Trading Arrangement | Total Shares to be Purchased or Sold | Duration/Expiration Date | ||
| Rule 10b5-1* | Non-Rule 10b5-1** | |||||
|---|---|---|---|---|---|---|
| Jesse J. Geiger, President | Adopt | October 27, 2025 [1] | X | Up to 23,028 shares to be sold | October 31, 2025 | |
| Susan E. Burwig, Executive Vice President, Operations | Adopt | October 27, 2025 [2] | X | Up to 20,000 shares to be sold | May 1, 2026 | |
| Jesse J. Geiger, President | Adopt | November 11, 2025 | X | Up to 11,000 shares to be sold | December 31, 2026 | |
| August J. Troendle, Chief Executive Officer and Chairman of the Board | Adopt | November 12, 2025 [3] | X | Up to 150,000 shares to be sold | Good until cancelled or until the commencement of the next blackout period, whichever occurs first | |
| Kevin M. Brady, Chief Financial Officer and Treasurer | Adopt | November 21, 2025 [4] | X | Up to 3,000 shares to be sold | The earlier of until cancelled or 180 days from the placement of the limit order | |
| Susan E. Burwig, Executive Vice President, Operations | Adopt | November 24, 2025 [5] | X | Up to 20,000 shares to be sold | May 22, 2026 | |
| August J. Troendle, Chief Executive Officer and Chairman of the Board | Adopt | November 24, 2025 [6] | X | Up to 150,000 shares to be sold | Good until cancelled or until the commencement of the next blackout period, whichever occurs first | |
| August J. Troendle, Chief Executive Officer and Chairman of the Board | Terminate | December 4, 2025 [7] | X | Up to 150,000 shares to be sold | Good until cancelled or until the commencement of the next blackout period, whichever occurs first | |
| * | Intended to satisfy the affirmative defense of Rule 10b5-1(c). |
|---|---|
| ** | Not intended to satisfy the affirmative defense of Rule 10b5-1(c). |
[1] On October 27, 2025, Mr. Geiger placed a limit order to sell up to 23,028 shares issued to him pursuant to his contemporaneous exercise of stock options. On October 27, 2025, Mr. Geiger sold 19,460 shares pursuant to the limit order. Mr. Geiger modified the limit price on October 28, 2025. On October 29, 2025, Mr. Geiger sold 3,568 shares pursuant to the limit order.
[2] On October 27, 2025, Ms. Burwig placed a limit order to sell up to 20,000 shares that were previously acquired through a stock option exercise.
- 78 -
[3] On November 12, 2025, Mr. Troendle placed a limit order to sell up to 150,000 shares. Mr. Troendle modified the limit price on November 14, 2025.
[4] On November 21, 2025, Mr. Brady placed a limit order to sell up to 3,000 shares issued to him pursuant to his contemporaneous exercise of stock options.
[5] On November 24, 2025, Ms. Burwig placed a limit order to sell up to 20,000 shares that were previously acquired through a stock option exercise.
[6] On November 24, 2025, Mr. Troendle placed a limit order to sell up to 150,000 shares.
[7] On December 4, 2025, Mr. Troendle terminated the limit order originally adopted on November 24, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.